2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea

As in other countries, type 2 diabetes is major health concern in Korea. A dramatic increase in the prevalence of type 2 diabetes and its chronic complications has led to an increase in health costs and economic burdens. Early detection of high risk individuals, hidden diabetic patients, and improve...

Full description

Bibliographic Details
Main Authors:	Ko, Seung-Hyun, Kim, Sung-Rea, Kim, Dong-Joon, Oh, Seung-Joon, Lee, Hye-Jin, Shim, Kang-Hee, Woo, Mi-Hye, Kim, Jun-Young, Kim, Nan-Hee, Kim, Jae-Taik, Kim, Chong Hwa, Kim, Hae Jin, Jeong, In-Kyung, Hong, Eun-Kyung, Cho, Jae-Hyoung, Mok, Ji-Oh, Yoon, Kun-Ho
Format:	Online
Language:	English
Published:	Korean Diabetes Association 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221016/

id	pubmed-3221016
recordtype	oai_dc
spelling	pubmed-32210162011-11-22 2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea Ko, Seung-Hyun Kim, Sung-Rea Kim, Dong-Joon Oh, Seung-Joon Lee, Hye-Jin Shim, Kang-Hee Woo, Mi-Hye Kim, Jun-Young Kim, Nan-Hee Kim, Jae-Taik Kim, Chong Hwa Kim, Hae Jin Jeong, In-Kyung Hong, Eun-Kyung Cho, Jae-Hyoung Mok, Ji-Oh Yoon, Kun-Ho Review As in other countries, type 2 diabetes is major health concern in Korea. A dramatic increase in the prevalence of type 2 diabetes and its chronic complications has led to an increase in health costs and economic burdens. Early detection of high risk individuals, hidden diabetic patients, and improvement in the quality of care for the disease are the first steps to mitigate the increase in prevalence. The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the '3rd Clinical Practice Guidelines' at the end of 2010. In the guidelines, the committee recommended active screening of high risk individuals for early detection and added the hemoglobin A1c level to the diagnostic criteria for type 2 diabetes based on clinical studies performed in Korea. Furthermore, the committee members emphasized that integrating patient education and self-management is an essential part of care. The drug treatment algorithm based on the degree of hyperglycemia and patient characteristics were also updated. Korean Diabetes Association 2011-10 2011-10-31 /pmc/articles/PMC3221016/ /pubmed/22111032 http://dx.doi.org/10.4093/dmj.2011.35.5.431 Text en Copyright © 2011 Korean Diabetes Association http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Ko, Seung-Hyun Kim, Sung-Rea Kim, Dong-Joon Oh, Seung-Joon Lee, Hye-Jin Shim, Kang-Hee Woo, Mi-Hye Kim, Jun-Young Kim, Nan-Hee Kim, Jae-Taik Kim, Chong Hwa Kim, Hae Jin Jeong, In-Kyung Hong, Eun-Kyung Cho, Jae-Hyoung Mok, Ji-Oh Yoon, Kun-Ho
spellingShingle	Ko, Seung-Hyun Kim, Sung-Rea Kim, Dong-Joon Oh, Seung-Joon Lee, Hye-Jin Shim, Kang-Hee Woo, Mi-Hye Kim, Jun-Young Kim, Nan-Hee Kim, Jae-Taik Kim, Chong Hwa Kim, Hae Jin Jeong, In-Kyung Hong, Eun-Kyung Cho, Jae-Hyoung Mok, Ji-Oh Yoon, Kun-Ho 2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea
author_facet	Ko, Seung-Hyun Kim, Sung-Rea Kim, Dong-Joon Oh, Seung-Joon Lee, Hye-Jin Shim, Kang-Hee Woo, Mi-Hye Kim, Jun-Young Kim, Nan-Hee Kim, Jae-Taik Kim, Chong Hwa Kim, Hae Jin Jeong, In-Kyung Hong, Eun-Kyung Cho, Jae-Hyoung Mok, Ji-Oh Yoon, Kun-Ho
author_sort	Ko, Seung-Hyun
title	2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea
title_short	2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea
title_full	2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea
title_fullStr	2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea
title_full_unstemmed	2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea
title_sort	2011 clinical practice guidelines for type 2 diabetes in korea
description	As in other countries, type 2 diabetes is major health concern in Korea. A dramatic increase in the prevalence of type 2 diabetes and its chronic complications has led to an increase in health costs and economic burdens. Early detection of high risk individuals, hidden diabetic patients, and improvement in the quality of care for the disease are the first steps to mitigate the increase in prevalence. The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the '3rd Clinical Practice Guidelines' at the end of 2010. In the guidelines, the committee recommended active screening of high risk individuals for early detection and added the hemoglobin A1c level to the diagnostic criteria for type 2 diabetes based on clinical studies performed in Korea. Furthermore, the committee members emphasized that integrating patient education and self-management is an essential part of care. The drug treatment algorithm based on the degree of hyperglycemia and patient characteristics were also updated.
publisher	Korean Diabetes Association
publishDate	2011
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221016/
_version_	1611489126611156992

2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea

Similar Items